Iterum Therapeutics plc(NASDAQ:ITRM) 
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials ...
Website: http://www.iterumtx.com
Founded: 2015
Full Time Employees: 44
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.16
H 1.24
L 1.09
C 1.13
V 527,665
10EMA 1.13
20EMA 1.13
60EMA 1.13
120EMA 1.13
250EMA 1.13